{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:57:44Z","timestamp":1791910664237,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.sleep.2024.07.037","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T09:41:48Z","timestamp":1722591708000},"page":"27-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Daridorexant in Japanese patients with insomnia disorder: A phase 3, randomized, double-blind, placebo-controlled study"],"prefix":"10.1016","volume":"122","author":[{"given":"Naohisa","family":"Uchimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsutaka","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ariyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Togo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.sleep.2024.07.037_bib1","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.5664\/jcsm.9476","article-title":"Sleep is essential to health: an American Academy of Sleep Medicine position statement","volume":"17","author":"Ramar","year":"2021","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"10.1016\/j.sleep.2024.07.037_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170772","article-title":"The prevalence of insomnia in the general population in China: a meta-analysis","volume":"12","author":"Cao","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.sleep.2024.07.037_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/sleep\/23.1.1a","article-title":"An epidemiological study of insomnia among the Japanese general population","volume":"23","author":"Kim","year":"2000","journal-title":"Sleep"},{"issue":"5 Suppl","key":"10.1016\/j.sleep.2024.07.037_bib4","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.5664\/jcsm.26929","article-title":"Insomnia: definition, prevalence, etiology, and consequences","volume":"3","author":"Roth","year":"2007","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleep.2024.07.037_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.sleep.2016.05.013","article-title":"Nationwide epidemiological study of insomnia in Japan","volume":"25","author":"Itani","year":"2016","journal-title":"Sleep Med"},{"issue":"1","key":"10.1016\/j.sleep.2024.07.037_bib6","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1186\/s12889-023-16329-9","article-title":"The burden of untreated insomnia disorder in a sample of 1 million adults: a cohort study","volume":"23","author":"Grandner","year":"2023","journal-title":"BMC Publ Health"},{"key":"10.1016\/j.sleep.2024.07.037_bib7","series-title":"Diagnostic and statistical manual of mental disorders: DSM-5","year":"2013"},{"key":"10.1016\/j.sleep.2024.07.037_bib8","first-page":"916","author":"Ito","year":"2015"},{"issue":"2","key":"10.1016\/j.sleep.2024.07.037_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7326\/M15-2175","article-title":"Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians","volume":"165","author":"Qaseem","year":"2016","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.sleep.2024.07.037_bib10","first-page":"1036","article-title":"[Clinical Practice Guideline for the proper use and cessation of hypnotics]","volume":"73","author":"Mishima","year":"2015","journal-title":"Nihon Rinsho"},{"issue":"6","key":"10.1016\/j.sleep.2024.07.037_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.14035","article-title":"The European Insomnia Guideline: an update on the diagnosis and treatment of insomnia 2023","volume":"32","author":"Riemann","year":"2023","journal-title":"J Sleep Res"},{"issue":"1","key":"10.1016\/j.sleep.2024.07.037_bib12","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12888-023-04683-2","article-title":"Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database","volume":"23","author":"Okuda","year":"2023","journal-title":"BMC Psychiatr"},{"key":"10.1016\/j.sleep.2024.07.037_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/1179573518770672","article-title":"Pharmacotherapy of insomnia","volume":"10","author":"Neubauer","year":"2018","journal-title":"J Cent Nerv Syst Dis"},{"issue":"Suppl","key":"10.1016\/j.sleep.2024.07.037_bib14","first-page":"14","article-title":"Issues in the use of benzodiazepine therapy","volume":"53","author":"Roth","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.sleep.2024.07.037_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1168100","article-title":"Treatment strategy for insomnia disorder: Japanese expert consensus","volume":"14","author":"Takaesu","year":"2023","journal-title":"Front Psychiatr"},{"issue":"8","key":"10.1016\/j.sleep.2024.07.037_bib16","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.5664\/jcsm.7282","article-title":"An update on dual orexin receptor antagonists and their potential role in insomnia therapeutics","volume":"14","author":"Janto","year":"2018","journal-title":"J Clin Sleep Med"},{"issue":"5","key":"10.1016\/j.sleep.2024.07.037_bib17","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/cpt.1046","article-title":"Accelerated development of the dual orexin receptor antagonist ACT-541468: integration of a microtracer in a first-in-human study","volume":"104","author":"Muehlan","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.sleep.2024.07.037_bib18","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.euroneuro.2019.05.009","article-title":"Multiple-dose clinical pharmacology of ACT-541468, a novel dual orexin receptor antagonist, following repeated-dose morning and evening administration","volume":"29","author":"Muehlan","year":"2019","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.sleep.2024.07.037_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/JCP.0000000000001182","article-title":"Pharmacokinetics and pharmacodynamics of the dual orexin receptor antagonist daridorexant in Japanese and Caucasian subjects","volume":"40","author":"Muehlan","year":"2020","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.sleep.2024.07.037_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.14302","article-title":"Pharmacokinetics, safety, and efficacy of daridorexant in Japanese subjects: results from Phase 1 and 2 studies","author":"Uchiyama","year":"2024","journal-title":"J Sleep Res"},{"key":"10.1016\/j.sleep.2024.07.037_bib21","doi-asserted-by":"crossref","first-page":"e2222","DOI":"10.1212\/WNL.0000000000009475","article-title":"Daridorexant, a new dual orexin receptor antagonist, in elderly subjects with insomnia disorder","volume":"94","author":"Zammit","year":"2020","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.sleep.2024.07.037_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ana.25680","article-title":"Daridorexant, a new dual orexin receptor antagonist to treat insomnia disorder","volume":"87","author":"Dauvilliers","year":"2020","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.sleep.2024.07.037_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1474-4422(21)00436-1","article-title":"Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials","volume":"21","author":"Mignot","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.sleep.2024.07.037_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40271-020-00474-z","article-title":"Development and validation of the insomnia daytime symptoms and impacts questionnaire (IDSIQ)","volume":"14","author":"Hudgens","year":"2021","journal-title":"Patient"},{"issue":"5","key":"10.1016\/j.sleep.2024.07.037_bib25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/sleep\/34.5.601","article-title":"The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response","volume":"34","author":"Morin","year":"2011","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.sleep.2024.07.037_bib26","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.sleep.2008.04.015","article-title":"Development of a Japanese version of the Epworth Sleepiness Scale (JESS) based on item response theory","volume":"10","author":"Takegami","year":"2009","journal-title":"Sleep Med"},{"issue":"1","key":"10.1016\/j.sleep.2024.07.037_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40263-022-00980-8","article-title":"Long-term safety and tolerability of daridorexant in patients with insomnia disorder","volume":"37","author":"Kunz","year":"2023","journal-title":"CNS Drugs"},{"key":"10.1016\/j.sleep.2024.07.037_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2020.08.1673","article-title":"PNS229 using MIXED methods to explore the content validity and importance of various SLEEP parameters in a SLEEP diary questionnaire","volume":"23","author":"Beyer","year":"2020","journal-title":"Value Health"},{"key":"10.1016\/j.sleep.2024.07.037_bib29","first-page":"291","article-title":"Meaningful within-patient change on the insomnia daytime symptoms and impacts questionnaire (IDSIQ): analysis of phase III clinical trial data of daridorexant","volume":"37","author":"Phillips-Beyer","year":"2023","journal-title":"Pharmaceut Med"},{"issue":"11","key":"10.1016\/j.sleep.2024.07.037_bib30","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.5665\/sleep.4170","article-title":"Insomnia symptoms and risk for unintentional fatal injuries--the HUNT Study","volume":"37","author":"Laugsand","year":"2014","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.sleep.2024.07.037_bib31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1207\/s15402010bsm0302_2","article-title":"Focusing on the experience of insomnia","volume":"3","author":"Carey","year":"2005","journal-title":"Behav Sleep Med"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945724003551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945724003551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T22:21:11Z","timestamp":1725834071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945724003551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":31,"alternative-id":["S1389945724003551"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2024.07.037","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daridorexant in Japanese patients with insomnia disorder: A phase 3, randomized, double-blind, placebo-controlled study","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2024.07.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}